Proteonomix, Inc.

Proteonomix, Inc.

PROT - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$791
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Proteonomix, Inc.Proteonomix, Inc.0-267%--5.5

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$791.00
Enterprise Value$823,844.00
Earnings per Share$-0.21
Beta2.47
Outstanding Shares7,888,000

Return

Return on Equity266.72%ROE
Return on Assets-27.08%
Return on Invested Capital256.52%

Valuation & Multiples

P/E Ratio0P/E Ratio
PEG0PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.0Price to Book Ratio
Enterprise Value to Revenue50.5
Enterprise Value to EBIT-0.55
Enterprise Value to Net Income-1
Total Debt to Enterprise3.91
Debt to Equity-5.51Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Proteonomix, Inc.

164 employees
CEO: Michael Moshe Cohen

Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company’s products include Proteoderm, an anti-aging skin cream based on a proprietary and patent...